Page 1 of Clinical Trials for Second line, 1573 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
Last Updated: August 29, 2011
Condition(s): HIV Infections
2
Recruiting
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Last Updated: March 12, 2012
Condition(s): HIV; HIV Infections
3
Not yet recruiting
Sequential Therapy Versus Quadriple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection
Last Updated: November 27, 2011
Condition(s): H Pylori Treatment
4
Completed
A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)
Last Updated: August 3, 2011
Condition(s): Non-Small Cell Lung Cancer; Brain Neoplasms
5
Active, not recruiting
MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)
Last Updated: January 5, 2012
Condition(s): Metastatic Colorectal Cancer
6
Active, not recruiting
Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
Last Updated: April 13, 2012
Condition(s): Renal Cell Carcinoma
7
Not yet recruiting
A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir
Last Updated: March 14, 2012
Condition(s): HIV
8
Not yet recruiting
A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations
Last Updated: May 26, 2010
Condition(s): Neoplasms, Lung; Carcinoma, Non-Small Cell Lung; Drug Therapy; Genes, EGFR
9
Active, not recruiting
A Trial for Treatment of Stage IIIB or IV Non-Small Cell Lung Cancer
Last Updated: July 19, 2011
Condition(s): Non Small Cell Lung Cancer
10
Recruiting
Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma
Last Updated: April 29, 2012
Condition(s): Metastatic Renal Cell Carcinoma
11
Suspended
Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma
Last Updated: August 20, 2010
Condition(s): Urothelial Carcinoma
12
Completed
Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer
Last Updated: January 10, 2012
Condition(s): Breast Cancer
13
Active, not recruiting
TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer
Last Updated: November 19, 2009
Condition(s): Advanced Non-Small Cell Lung Cancer
14
Not yet recruiting
Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy
Last Updated: February 21, 2012
Condition(s): Eradication Rate for Helicobacter
15
Active, not recruiting
Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma
Last Updated: April 26, 2012
Condition(s): Gastric Adenocarcinoma; Gastroesophageal Adenocarcinoma; Esophageal Adenocarcinoma
16
Not yet recruiting
Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients
Last Updated: March 30, 2009
Condition(s): Acquired Immune Deficiency Syndrome; HIV Infections
17
Completed
Study to Evaluate Safety and Feasibility of Using OGX-011 in Combination With Second Line Chemotherapy in Patients With HRPC
Last Updated: July 11, 2011
Condition(s): Prostate Cancer
18
Terminated
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
Last Updated: March 1, 2012
Condition(s): Hepatocellular Carcinoma
19
Not yet recruiting
Pazopanib in Second-line Therapy in Renal Cell Carcinoma
Last Updated: April 13, 2012
Condition(s): Metastatic Renal Cell Carcinoma
20
Completed
The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study
Last Updated: April 21, 2011
Condition(s): H. Pylori Infection

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Second+line

Page 1 of Clinical Trials for Second line, 1573 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About